Experienced in Pancreatectomy

Dr. Chi S. Lin

Unmc Physicians
Shenandoah, IA
Experienced
in Pancreatectomy
Specialties:Radiation Oncology
Accepting New Patients
Offers Telehealth
OverviewInsuranceLocationsClinical Research

Overview

Chi Lin is a Radiation Oncologist in Shenandoah, Iowa. Dr. Lin and is rated as an Experienced provider by MediFind in Pancreatectomy. Her top areas of expertise are Pancreatic Cancer, Anal Cancer, Lung Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Lin is currently accepting new patients.

Her clinical research consists of co-authoring 127 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Pancreatectomy.

Specialties
Radiation Oncology
Licenses
Radiology in NE
Hospital Affiliations
Bellevue Medical Center, LLC
The Nebraska Medical Center
Languages Spoken
English
American Sign Language
Mandarin
Sign Language
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Wellmark
  •  Medica
  •  Oscar

Locations

UNMC PHYSICIANS
300 Pershing Ave, Shenandoah, IA 51601
402-559-6195
Other Locations
UNMC PHYSICIANS
Emile 42nd St, Omaha, NE 68198
402-559-4015

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
A Phase II Study of Neoadjuvant Chemotherapy With and Without Immunotherapy to CA125 (Oregovomab) Followed by Hypofractionated Stereotactic Radiotherapy & Concurrent HIV Protease Inhibitor Nelfinavir in Locally Advanced Pancreatic Cancer
A Phase II Study of Neoadjuvant Chemotherapy With and Without Immunotherapy to CA125 (Oregovomab) Followed by Hypofractionated Stereotactic Radiotherapy & Concurrent HIV Protease Inhibitor Nelfinavir in Locally Advanced Pancreatic Cancer
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Drug, Other, Biological, Procedure, Radiation
Study Phase: Phase 2
View 1 Less Clinical Trial

127 Total Publications

Role of immunotherapy in the overall survival of gastrointestinal cancer patients with liver metastases.
Role of immunotherapy in the overall survival of gastrointestinal cancer patients with liver metastases.
Journal: Hepatic oncology
Published: January 30, 2025

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile